Federal award (DEFINITIVE CONTRACT, fiscal year 2023)
Recipient: GENCYTE THERAPEUTICS INC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2023-02-27 to 2024-08-26
Current total value of award: $354964
Description: THE PURPOSE OF THIS MODIFICATION IS TO EXTEND THE PERIOD OF PERFORMANCE FROM FEBRUARY 26, 2024 TO AUGUST 26, 2024